Fed. Circ. Nixes Intema Fetal Test Patent Under Mayo
Citing the U.S. Supreme Court's Mayo v. Prometheus decision, the Federal Circuit ruled Tuesday that an Intema Ltd. patent on a fetal Down syndrome screening test is not patent eligible because...To view the full article, register now.
Already a subscriber? Click here to view full article